Innovaderm Research Inc.

The trials here

What the 23 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)12 trials
• Psoriasis8 trials
• Alopecia areata5 trials
• Hidradenitis suppurativa3 trials
• Vitiligo2 trials
• Chronic spontaneous urticaria1 trial

Phase

• Phase 313 trials
• Phase 23 trials
• Phase 11 trial
• Phase 1/21 trial
• Phase 2/31 trial
• Phase 41 trial

Status

• Completed10 trials
• Active, not recruiting9 trials
• Recruiting2 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• Pfizer6 trials
• Janssen Research & Development, LLC4 trials
• Amgen2 trials
• Innovaderm Research Inc.2 trials
• Escient Pharmaceuticals, Inc1 trial
• and 8 more

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  NCT07783425· Phase 3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  NCT07765888· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

  NCT07244263· Phase 2· Takeda· Source

• Active, not recruiting

  A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

  NCT06934226· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

  NCT06873945· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

  NCT06220604· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

• Recruiting

  Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

  NCT05994976· Innovaderm Research Inc.· Source

  Contact: Valérie Piché Richard, MSc

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

  NCT06095102· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

  NCT06095115· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

  NCT03898479· Phase 2/3· Sun Pharmaceutical Industries, Inc.· Source

• Active, not recruiting

  A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

  NCT03661866· Target PharmaSolutions, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)3 recruiting
• Hidradenitis suppurativa1 recruiting
• Psoriasis1 recruiting

Closed trials

• Completed

  A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

  NCT06934980· Incyte Corporation· Source

• Completed

  Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)

  NCT06101823· Phase 2· Insmed Incorporated· Source

• Completed

  Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

  NCT06144424· Phase 2· Escient Pharmaceuticals, Inc· Source

• Completed

  A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants

  NCT06060977· Phase 1/2· Inmagene LLC· Source

• Completed

  Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis

  NCT05844618· Phase 4· Innovaderm Research Inc.· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source

• Terminated

  Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

  NCT06005792· Phase 1· Xencor, Inc.· Source

• Completed

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· Phase 3· Amgen· Source

• Completed

  Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

  NCT05172726· Phase 3· Organon and Co· Source

• Completed

  Long-Term PF-06651600 for the Treatment of Alopecia Areata

  NCT04006457· Phase 3· Pfizer· Source

• Completed

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· Phase 3· Pfizer· Source